Wave Life Sciences Ltd. 8-K Filing
Ticker: WVE · Form: 8-K · Filed: Nov 17, 2025 · CIK: 1631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | 8-K |
| Filed Date | Nov 17, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Wave Life Sciences Ltd. (ticker: WVE) to the SEC on Nov 17, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0 (e of each exchange on which registered $0 Par Value Ordinary Shares WVE The N).
How long is this filing?
Wave Life Sciences Ltd.'s 8-K filing is 2 pages with approximately 544 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 544 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-11-17 07:30:28
Key Financial Figures
- $0 — e of each exchange on which registered $0 Par Value Ordinary Shares WVE The N
Filing Documents
- d68638d8k.htm (8-K) — 24KB
- d68638dex991.htm (EX-99.1) — 63KB
- g68638dsp001.jpg (GRAPHIC) — 263KB
- g68638dsp002.jpg (GRAPHIC) — 251KB
- g68638dsp003.jpg (GRAPHIC) — 341KB
- g68638dsp004.jpg (GRAPHIC) — 274KB
- g68638dsp005.jpg (GRAPHIC) — 193KB
- g68638dsp006.jpg (GRAPHIC) — 189KB
- g68638dsp007.jpg (GRAPHIC) — 127KB
- g68638dsp008.jpg (GRAPHIC) — 221KB
- g68638dsp009.jpg (GRAPHIC) — 256KB
- g68638dsp010.jpg (GRAPHIC) — 221KB
- g68638dsp011.jpg (GRAPHIC) — 214KB
- g68638dsp012.jpg (GRAPHIC) — 240KB
- g68638dsp013.jpg (GRAPHIC) — 151KB
- g68638dsp014.jpg (GRAPHIC) — 189KB
- g68638dsp015.jpg (GRAPHIC) — 190KB
- g68638dsp016.jpg (GRAPHIC) — 153KB
- g68638dsp017.jpg (GRAPHIC) — 147KB
- g68638dsp018.jpg (GRAPHIC) — 179KB
- g68638dsp019.jpg (GRAPHIC) — 187KB
- g68638dsp020.jpg (GRAPHIC) — 156KB
- g68638dsp021.jpg (GRAPHIC) — 236KB
- g68638dsp022.jpg (GRAPHIC) — 264KB
- g68638dsp023.jpg (GRAPHIC) — 172KB
- g68638dsp024.jpg (GRAPHIC) — 269KB
- g68638dsp025.jpg (GRAPHIC) — 265KB
- g68638dsp026.jpg (GRAPHIC) — 210KB
- g68638dsp027.jpg (GRAPHIC) — 227KB
- g68638dsp028.jpg (GRAPHIC) — 219KB
- g68638dsp029.jpg (GRAPHIC) — 131KB
- g68638dsp030.jpg (GRAPHIC) — 149KB
- g68638dsp031.jpg (GRAPHIC) — 230KB
- g68638dsp032.jpg (GRAPHIC) — 215KB
- g68638dsp033.jpg (GRAPHIC) — 267KB
- g68638dsp034.jpg (GRAPHIC) — 227KB
- g68638dsp035.jpg (GRAPHIC) — 279KB
- g68638dsp036.jpg (GRAPHIC) — 159KB
- g68638dsp037.jpg (GRAPHIC) — 131KB
- g68638dsp038.jpg (GRAPHIC) — 261KB
- g68638dsp039.jpg (GRAPHIC) — 284KB
- g68638dsp040.jpg (GRAPHIC) — 194KB
- g68638dsp041.jpg (GRAPHIC) — 184KB
- g68638dsp042.jpg (GRAPHIC) — 303KB
- g68638dsp043.jpg (GRAPHIC) — 173KB
- g68638dsp044.jpg (GRAPHIC) — 271KB
- g68638dsp045.jpg (GRAPHIC) — 235KB
- g68638dsp046.jpg (GRAPHIC) — 292KB
- g68638dsp047.jpg (GRAPHIC) — 177KB
- g68638dsp048.jpg (GRAPHIC) — 229KB
- g68638dsp049.jpg (GRAPHIC) — 133KB
- g68638dsp050.jpg (GRAPHIC) — 282KB
- g68638dsp051.jpg (GRAPHIC) — 269KB
- g68638dsp052.jpg (GRAPHIC) — 217KB
- g68638dsp053.jpg (GRAPHIC) — 169KB
- g68638dsp054.jpg (GRAPHIC) — 214KB
- g68638dsp055.jpg (GRAPHIC) — 140KB
- g68638dsp056.jpg (GRAPHIC) — 185KB
- g68638dsp057.jpg (GRAPHIC) — 138KB
- g68638dsp058.jpg (GRAPHIC) — 164KB
- 0001193125-25-283929.txt ( ) — 17182KB
- wve-20251117.xsd (EX-101.SCH) — 3KB
- wve-20251117_lab.xml (EX-101.LAB) — 18KB
- wve-20251117_pre.xml (EX-101.PRE) — 11KB
- d68638d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d)Exhibits. The following exhibit relating to Item 7.01 is furnished and not filed: Exhibit No. Description 99.1 Corporate Presentation of Wave Life Sciences Ltd. dated November 17, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WAVE LIFE SCIENCES LTD. By: /s/ Kyle Moran Kyle Moran Chief Financial Officer Date:November 17, 2025